<PAGE>
As filed with the Securities and Exchange Commission on April 25, 1997.
Registration No. 333-
================================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
--------------------
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
--------------------
RENAL TREATMENT CENTERS, INC.
----------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 23-2518331
- ------------------------------- -----------------
(State or other jurisdiction of I.R.S. Employer
incorporation or organization) Identification No.)
Building 2, Suite 300
1180 West Swedesford Road
Berwyn, Pennsylvania 19312
(610) 644-4796
------------------------------------------------
(Address, including zip code, and telephone number, including
area code, of registrant's principal executive offices)
--------------------
RENAL TREATMENT CENTERS, INC.
SAVINGS PLAN
------------------------------
(Full title of plan)
--------------------
Thomas J. Karl
Vice President, Secretary and General Counsel
Building 2, Suite 300
1180 West Swedesford Road
Berwyn, Pennsylvania 19312
(610) 644-4796
------------------------------
(Name, address, including zip code, and telephone number,
including area code, of agent for service)
--------------------
Copy to:
Kathleen M. Shay, Esquire
Duane, Morris & Heckscher
One Liberty Place
Philadelphia, PA 19103-7396
CALCULATION OF REGISTRATION FEE
<TABLE>
<CAPTION>
===================================================================================================================================
Proposed Proposed
Title of securities Amount to be maximum offering maximum aggregate Amount of
to be registered registered price per share offering price registration fee
- -----------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C>
Common Stock, 150,000 shares (1) $20.1875(1) $3,028,125 (1) $918
$.01 par value (1)
===================================================================================================================================
</TABLE>
(1) Pursuant to paragraph (h) of Rule 457, the proposed maximum offering
price per share and the proposed maximum aggregate offering price have
been computed on the basis of $20.1875 per share, the average of the high
and low sales prices of the Common Stock of the Company on the New York
Stock Exchange on April 23, 1997. In addition, pursuant to Rule 416(c)
under the Securities Act of 1933, this Registration Statement also covers
an indeterminate amount of interests to be offered or sold pursuant to
the above-referenced plan.
<PAGE>
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference.
The following material filed by Renal Treatment Centers, Inc. (the
"Company") or the Renal Treatment Centers, Inc. Savings Plan (the "Plan") with
the Securities and Exchange Commission (the "Commission") is incorporated herein
by reference:
(a) The Company's annual report filed pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934, as amended (the "Exchange Act"), for the
fiscal year ended December 31, 1996.
(b) The Plan's report on Form 11-K as of and for the nine months ended
December 31, 1996.
(c) The Company's current report filed pursuant to Section 13 or 15(d) of
the Exchange Act dated February 5, 1997.
(d) The description of the Company's Common Stock set forth in the
Company's Registration Statement No. 33-74994 on Form S-1, initially filed with
the Commission under the Securities Act of 1933, as amended (the "Securities
Act"), on February 4, 1994, under the caption "Description of Capital Stock -
Common Stock," which is incorporated by reference in response to Item 1 of
Registration Statement No. 1-14142 on Form 8-A filed by the Company with the
Commission on December 14, 1995 pursuant to Section 12(b) of the Exchange Act.
All reports or other documents subsequently filed by the Company or the
Plan pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act, prior
to the filing of a post-effective amendment that indicates that all securities
offered have been sold or that deregisters all securities then remaining unsold,
shall be deemed to be incorporated by reference in this Registration Statement
and to be a part hereof from the date of filing of such reports and documents.
Any statement contained in a document incorporated or deemed to be incorporated
herein by reference shall be deemed to be modified or superseded for the
purposes of this Registration Statement to the extent that a statement contained
herein or in any other subsequently filed document, which also is or is deemed
to be incorporated herein by reference, modifies or supersedes such statement.
Any statement so modified or superseded shall not be deemed, except as so
modified or superseded, to constitute a part of this Registration Statement.
II-1
<PAGE>
Item 4. Description of Securities.
No answer to this item is required because the class of securities to be
offered is registered under Section 12 of the Exchange Act and plan interests
need not be described pursuant to this item.
Item 5. Interests of Named Experts and Counsel.
Not applicable.
Item 6. Indemnification of Directors and Officers.
Section 145 of the General Corporation Law of the State of Delaware
empowers a Delaware corporation to indemnify any person who was or is a party or
is threatened to be made a party to any threatened, pending or completed action,
suit or proceeding, whether civil, criminal, administrative or investigative
(other than an action by or in the right of the corporation) by reason of the
fact that he is or was a director, officer, employee or agent of the
corporation, or is or was serving at the request of the corporation as a
director, officer, employee or agent of another corporation, partnership, joint
venture, trust or other enterprise, against expenses (including attorneys'
fees), judgments, fines and amounts paid in settlement actually and reasonably
incurred by him in connection with such action, suit or proceeding if he acted
in good faith and in a manner he reasonably believed to be in or not opposed to
the best interests of the corporation, and, with respect to any criminal action
or proceeding, had no reasonable cause to believe his conduct was unlawful. The
termination of any action, suit or proceeding by judgment, order, settlement,
conviction, or upon plea of nolo contendere or its equivalent, does not, of
itself, create a presumption that the person did not act in good faith and in a
manner which he reasonably believed to be in or not opposed to the best
interests of the corporation, and, with respect to any criminal action or
proceeding, had reasonable cause to believe that his conduct was unlawful.
In the case of an action or suit by or in the right of the corporation to
procure a judgment in its favor, Section 145 empowers a corporation to indemnify
any person who was or is a party or is threatened to be made a party to any
threatened, pending or completed action or suit by reason of the fact that he is
or was acting in any of the capacities set forth above against expenses
(including attorneys' fees) actually and reasonably incurred by him in
connection with the defense or settlement of such action or suit if he acted in
good faith and in a manner he reasonably believed to be in or not opposed to the
best interests of the corporation, except that indemnification is not permitted
in respect of any claim, issue or matter as to which such person is adjudged to
be liable to the corporation unless and only to the extent that the Court of
Chancery of the State of Delaware or the court in which such action or suit was
brought determines upon application that, despite the adjudication of liability
but in view of all the circumstances of the case, such person is fairly and
reasonably entitled to indemnity for such expenses which the Court of Chancery
or such other court deems proper.
II-2
<PAGE>
Section 145 further provides: that a Delaware corporation is required to
indemnify a director, officer, employee or agent against expenses (including
attorneys' fees) actually and reasonably incurred by him in defense of any
action, suit or proceeding referred to above or in defense of any claim, issue
or matter therein to the extent that such person has been successful on the
merits or otherwise; that the indemnification provided for by Section 145 shall
not be deemed exclusive of any other rights to which the indemnified party may
be entitled; that the indemnification provided for by Section 145 shall, unless
otherwise provided when authorized or ratified, continue as to a person who has
ceased to be a director, officer, employee or agent and shall inure to the
benefit of such person's heirs, executors and administrators; and empowers the
corporation to purchase and maintain insurance on behalf of any person who is or
was a director, officer, employee or agent of the corporation against any
liability asserted against him and incurred by him in any such capacity or
arising out of his status as such, whether or not the corporation would have the
power to indemnify him against such liability under Section 145. A Delaware
corporation may provide indemnification only as authorized in the specific case
upon a determination that indemnification of the director, officer, employee or
agent is proper in the circumstances because he has met the applicable standard
of conduct. Such determination is to be made (i) by the board of directors by a
majority vote of a quorum consisting of directors who were not parties to such
action, suit or proceeding, or (ii) if such a quorum is not obtainable, or, even
if obtainable a quorum of disinterested directors so directs, by independent
legal counsel in a written opinion or (iii) by the stockholders.
Article Eighth of the Company's Restated Certificate of Incorporation
provides for indemnification of directors and officers of the Company to the
fullest extent permitted by the General Corporation Law of the State of
Delaware, as presently or hereafter in effect.
The Company provides liability insurance for each director and officer for
certain losses arising from claims or charges made against them while acting in
their capacities as directors or officers of the Company up to an aggregate of
$5,000,000 inclusive of defense costs, expenses and charges.
Additionally, Article Seventh of the Company's Restated Certificate of
Incorporation limits the liability of the Company's directors to the fullest
extent permitted by Section 102(b)(7) of the General Corporation Law of the
State of Delaware, as the same may be amended and supplemented. Section
102(b)(7) permits the certificate of incorporation of a Delaware corporation to
include a provision eliminating or limiting the personal liability of a director
of a corporation to the corporation or its stockholders for monetary damages for
breach of his fiduciary duty as a director; provided, however, that the
provision may not eliminate or limit the liability of a director for (i) any
breach of the director's duty of loyalty to the corporation or its stockholders;
(ii) acts or omissions not in good faith or which involve intentional misconduct
or a knowing violation of law; (iii) the unlawful payment of dividends or
unlawful purchase or redemption of stock under Section 174 of the General
Corporation Law of the State of Delaware; or (iv) any transaction from which the
director derived an improper personal benefit.
II-3
<PAGE>
Item 7. Exemption from Registration Claimed.
Not applicable.
Item 8. Exhibits.
4.1 Specimen Certificate of Common Stock of the Company (incorporated
herein by reference to Exhibit No. 4.1 filed under the Company's
Annual Report on Form 10-K for the year ended December 31, 1995).
4.2 Restated Certificate of Incorporation of the Company (incorporated
herein by reference to Exhibit No. 3.1 filed under the Company's
Quarterly Report on Form 10-Q for the quarter ended March 31, 1996).
4.2.1 Certificate of Amendment dated February 29, 1996 to Restated
Certificate of Incorporation of the Company (incorporated herein by
reference to Exhibit No. 3.1.1 filed under the Company's Quarterly
Report on Form 10-Q for the quarter ended March 31, 1996).
4.3 By-Laws of the Company and Amendment to By-Laws adopted February 9,
1993 (incorporated herein by reference to Exhibit No. 3.2 filed under
the Company's Form S-1 Registration Statement No. 33-59850).
23.1 Consent of Coopers & Lybrand L.L.P.
23.2 Consent of Deloitte & Touche LLP.
23.3 Consent of Baird, Kurtz & Dobson.
Pursuant to instruction (b) under Item 8 of Form S-8, the registrant hereby
undertakes that it will submit, or has submitted, the Plan and, from time to
time, any amendments thereto to the Internal Revenue Service ("IRS") in a timely
manner and that it has made or will make all changes required by the IRS in
order to qualify the Plan.
Item 9. Undertakings.
The registrant hereby undertakes:
(1) to file, during any period in which offers or sales are being made, a
post-effective amendment to this Registration Statement:
(i) to include any prospectus required by Section 10(a)(3) of the
Securities Act;
II-4
<PAGE>
(ii) to reflect in the prospectus any facts or events
arising after the effective date of the
Registration Statement (or the most recent
post-effective amendment thereof) which,
individually or in the aggregate, represent a
fundamental change in the information set forth in
the Registration Statement; and
(iii) to include any material information with respect to
the plan of distribution not previously disclosed
in the Registration Statement or any material
change to such information in the Registration
Statement;
provided, however, that paragraphs (i) and (ii) do not apply if the information
required to be included in a post-effective amendment by those paragraphs is
contained in periodic reports filed with or furnished to the Commission by the
registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are
incorporated by reference in the Registration Statement.
(2) that for the purpose of determining any liability under the Securities
Act, each such post-effective amendment shall be deemed to be a new registration
statement relating to the securities offered therein, and the offering of such
securities at that time shall be deemed to be the initial bona fide offering
thereof; and
(3) to remove from registration by means of a post-effective amendment any
of the securities being registered which remain unsold at the termination of the
offering.
The undersigned registrant hereby further undertakes that, for purposes of
determining any liability under the Securities Act, each filing of the
registrant's annual report pursuant to Section 13(a) or Section 15(d) of the
Exchange Act (and, where applicable, each filing of an employee benefit plan's
annual report pursuant to Section 15(d) of the Exchange Act) that is
incorporated by reference in the Registration Statement shall be deemed to be a
new registration statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the initial bona
fide offering thereof.
Insofar as indemnification for liabilities arising under the Securities Act
of 1933 may be permitted to directors, officers and controlling persons of the
registrant, the registrant has been advised that in the opinion of the
Securities and Exchange Commission such indemnification is against public policy
as expressed in the Securities Act of 1933 and is, therefore, unenforceable. In
the event that a claim for indemnification against such liabilities (other than
the payment by the registrant of expenses incurred or paid by a director,
officer or controlling person of the registrant in the successful defense of any
action, suit or proceeding) is asserted by such director, officer or controlling
person in connection with the securities being registered, the registrant will,
unless in the opinion of its counsel the matter has been settled by controlling
precedent, submit to a court of appropriate jurisdiction the question whether
such indemnification by it is against public policy as expressed in the
Securities Act of 1933 and will be governed by the final adjudication of such
issue.
II-5
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-8 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in Berwyn, Pennsylvania on April 25, 1997.
RENAL TREATMENT CENTERS, INC.
By: /s/ Robert L. Mayer, Jr.
-----------------------------
Robert L. Mayer, Jr.,
President
Know all men by these presents, that each person whose signature appears
below constitutes and appoints Thomas J. Karl and Ronald H. Rodgers, Jr., and
each or any of them, as his true and lawful attorneys-in-fact and agents, with
full power of substitution, for him, and in his name, place and stead, in any
and all capacities to sign any or all amendments or post-effective amendments to
this Registration Statement, and to file the same, with all exhibits thereto and
other documents in connection therewith, with the Securities and Exchange
Commission, granting unto said attorneys-in-fact and agents full power and
authority to do and perform each and every act and thing requisite and necessary
to be done in and about the premises, as fully to all intents and purposes as he
might or could do in person, hereby ratifying and confirming all that said
attorneys-in-fact and agents, or any of them or their substitutes, may lawfully
do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed below by the following persons in the
capacities and on the dates indicated.
<TABLE>
<CAPTION>
Signature Title Date
--------- ----- ----
<S> <C> <C>
/s/ Robert L. Mayer, Jr. President and Director April 25, 1997
- --------------------------------------- (principal executive officer)
Robert L. Mayer, Jr.
/s/ Frederick C. Jansen Executive Vice President April 25, 1997
- --------------------------------------- and Director
Frederick C. Jansen
/s/ Ronald H. Rodgers, Jr. Vice President of Finance April 25, 1997
- --------------------------------------- and Chief Financial Officer
Ronald H. Rodgers, Jr. (principal financial and accounting officer)
/s/ Claire W. Gargalli Director April 25, 1997
- ---------------------------------------
Claire W. Gargalli
/s/ Patrick T. Ryan Director April 25, 1997
- ---------------------------------------
Patrick T. Ryan
/s/ Michael R. Walker Director April 25, 1997
- ---------------------------------------
Michael R. Walker
</TABLE>
<PAGE>
The Plan. Pursuant to the requirements of the Securities Act of 1933, the
trustees (or other persons who administer the Plan) have duly caused this
Registration Statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in Berwyn, Pennsylvania, on April 25, 1997.
RENAL TREATMENT CENTERS, INC.
SAVINGS PLAN
By: /s/ Michael Cutuli
-----------------------------
Michael Cutuli
Plan Administrator
<PAGE>
EXHIBIT INDEX
(Pursuant to Item 601 of Regulation S-K)
<TABLE>
Exhibit No. Exhibit
<S> <C>
4.1 Specimen Certificate of Common Stock of the Company (incorporated
herein by reference to Exhibit No. 4.1 filed under the Company's
Annual Report on Form 10-K for the year ended December 31, 1995).
4.2 Restated Certificate of Incorporation of the Company (incorporated
herein by reference to Exhibit No. 3.1 filed under the Company's
Quarterly Report on Form 10-Q for the quarter ended March 31, 1996).
4.2.1 Certificate of Amendment dated February 29, 1996 to Restated
Certificate of Incorporation of the Company (incorporated herein by
reference to Exhibit No. 3.1.1 filed under the Company's Quarterly
Report on Form 10-Q for the quarter ended March 31, 1996).
4.3 By-Laws of the Company and Amendment to By-Laws adopted February 9,
1993 (incorporated herein by reference to Exhibit No. 3.2 filed
under the Company's Form S-1 Registration Statement No. 33-59850).
23.1 Consent of Coopers & Lybrand L.L.P.
23.2 Consent of Deloitte & Touche LLP.
23.3 Consent of Baird, Kurtz & Dobson.
</TABLE>
<PAGE>
EXHIBIT 23.1
CONSENT OF INDEPENDENT ACCOUNTANTS
We consent to the incorporation by reference in this registration statement on
Form S-8 of our report dated February 7, 1997, which includes reference to
information audited by other auditors for which the dates of their reports are
July 14, 1995 and March 31, 1995, on our audits of the financial statements and
financial statement schedule of Renal Treatment Centers, Inc. as of December 31,
1996 and 1995 and for each of the three years in the period ended December 31,
1996 and our report dated April 4, 1997 on our audit of the financial statements
of Renal Treatment Centers, Inc. Savings Plan as of and for the nine months
ended December 31, 1996.
/s/ Coopers & Lybrand L.L.P.
Coopers & Lybrand L.L.P.
Wayne, Pennsylvania
April 24, 1997
<PAGE>
EXHIBIT 23.2
INDEPENDENT AUDITORS' CONSENT
We consent to the incorporation by reference in this Registration Statement of
Renal Treatment Centers, Inc. on Form S-8 of our report dated March 31, 1995,
appearing in the Annual Report on Form 10-K of Renal Treatment Centers, Inc.
for the year ended December 31, 1996.
/s/ Deloitte & Touche LLP
DELOITTE & TOUCHE LLP
Nashville, Tennessee
April 21, 1997
<PAGE>
EXHIBIT 23.3
CONSENT OF INDEPENDENT ACCOUNTANTS
We consent to the incorporation by reference in this Registration Statement of
Renal Treatment Centers, Inc. on Form S-8 of our report dated July 14, 1995,
except for Note 9 as to which the date is July 24, 1995, relating to the
financial statements of the Wichita Dialysis Group, appearing in the Form 10-K
Annual Report of Renal Treatment Centers, Inc. for the year ended December 31,
1996.
/s/ Baird, Kurtz & Dobson
BAIRD, KURTZ & DOBSON
Wichita, Kansas
April 21, 1997
